Literature DB >> 25587033

Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity.

Lily L Jin1, Leanne E Wybenga-Groot2, Jiefei Tong3, Paul Taylor3, Mark D Minden4, Suzanne Trudel4, C Jane McGlade5, Michael F Moran6.   

Abstract

Src homology 2 (SH2) domains are modular protein structures that bind phosphotyrosine (pY)-containing polypeptides and regulate cellular functions through protein-protein interactions. Proteomics analysis showed that the SH2 domains of Src family kinases are themselves tyrosine phosphorylated in blood system cancers, including acute myeloid leukemia, chronic lymphocytic leukemia, and multiple myeloma. Using the Src family kinase Lyn SH2 domain as a model, we found that phosphorylation at the conserved SH2 domain residue Y(194) impacts the affinity and specificity of SH2 domain binding to pY-containing peptides and proteins. Analysis of the Lyn SH2 domain crystal structure supports a model wherein phosphorylation of Y(194) on the EF loop modulates the binding pocket that engages amino acid side chains at the pY+2/+3 position. These data indicate another level of regulation wherein SH2-mediated protein-protein interactions are modulated by SH2 kinases and phosphatases.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25587033      PMCID: PMC4349988          DOI: 10.1074/mcp.M114.044404

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  50 in total

1.  Loops govern SH2 domain specificity by controlling access to binding pockets.

Authors:  Tomonori Kaneko; Haiming Huang; Bing Zhao; Lei Li; Huadong Liu; Courtney K Voss; Chenggang Wu; Martin R Schiller; Shawn Shun-Cheng Li
Journal:  Sci Signal       Date:  2010-05-04       Impact factor: 8.192

2.  Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemia.

Authors:  Christine I Chen; P Leif Bergsagel; Harminder Paul; Wei Xu; Anthea Lau; Nimisha Dave; Vishal Kukreti; Ellen Wei; Chungyee Leung-Hagesteijn; Zhi Hua Li; Joseph Brandwein; Mariela Pantoja; James Johnston; Spencer Gibson; Tiffany Hernandez; David Spaner; Suzanne Trudel
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

Review 3.  The interplay between Src family kinases and receptor tyrosine kinases.

Authors:  Paul A Bromann; Hasan Korkaya; Sara A Courtneidge
Journal:  Oncogene       Date:  2004-10-18       Impact factor: 9.867

4.  Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry.

Authors:  Lily L Jin; Jiefei Tong; Amol Prakash; Scott M Peterman; Jonathan R St-Germain; Paul Taylor; Suzanne Trudel; Michael F Moran
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

5.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

6.  Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition.

Authors:  Jonathan R St-Germain; Paul Taylor; Jiefei Tong; Lily L Jin; Ana Nikolic; Ian I Stewart; Robert M Ewing; Moyez Dharsee; Zhihua Li; Suzanne Trudel; Michael F Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

7.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

8.  GeneCards Version 3: the human gene integrator.

Authors:  Marilyn Safran; Irina Dalah; Justin Alexander; Naomi Rosen; Tsippi Iny Stein; Michael Shmoish; Noam Nativ; Iris Bahir; Tirza Doniger; Hagit Krug; Alexandra Sirota-Madi; Tsviya Olender; Yaron Golan; Gil Stelzer; Arye Harel; Doron Lancet
Journal:  Database (Oxford)       Date:  2010-08-05       Impact factor: 3.451

9.  An introduction to data reduction: space-group determination, scaling and intensity statistics.

Authors:  Philip R Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  13 in total

1.  A Phosphosite within the SH2 Domain of Lck Regulates Its Activation by CD45.

Authors:  Adam H Courtney; Jeanine F Amacher; Theresa A Kadlecek; Marianne N Mollenauer; Byron B Au-Yeung; John Kuriyan; Arthur Weiss
Journal:  Mol Cell       Date:  2017-07-20       Impact factor: 17.970

Review 2.  Src Family Protein Kinase Controls the Fate of B Cells in Autoimmune Diseases.

Authors:  Xianzheng Zhang; Dan Mei; Lingling Zhang; Wei Wei
Journal:  Inflammation       Date:  2020-10-10       Impact factor: 4.092

3.  Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder.

Authors:  Yangyang Bian; Lei Li; Mingming Dong; Xuguang Liu; Tomonori Kaneko; Kai Cheng; Huadong Liu; Courtney Voss; Xuan Cao; Yan Wang; David Litchfield; Mingliang Ye; Shawn S-C Li; Hanfa Zou
Journal:  Nat Chem Biol       Date:  2016-09-19       Impact factor: 15.040

4.  Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacity.

Authors:  Marion E Weir; Jacqueline E Mann; Thomas Corwin; Zachary W Fulton; Jennifer M Hao; Jeanine F Maniscalco; Marie C Kenney; Kristal M Roman Roque; Elizabeth F Chapdelaine; Ulrich Stelzl; Paula B Deming; Bryan A Ballif; Karen L Hinkle
Journal:  FEBS Lett       Date:  2016-04-13       Impact factor: 4.124

5.  In Vivo Phosphoproteome Analysis Reveals Kinome Reprogramming in Hepatocellular Carcinoma.

Authors:  Liangliang Ren; Chaoying Li; Youliang Wang; Yan Teng; Huichuan Sun; Baocai Xing; Xiao Yang; Ying Jiang; Fuchu He
Journal:  Mol Cell Proteomics       Date:  2018-02-22       Impact factor: 5.911

Review 6.  TCR Signaling: Mechanisms of Initiation and Propagation.

Authors:  Adam H Courtney; Wan-Lin Lo; Arthur Weiss
Journal:  Trends Biochem Sci       Date:  2017-12-18       Impact factor: 13.807

Review 7.  Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia.

Authors:  Maria Hernandez-Valladares; Elise Aasebø; Frode Selheim; Frode S Berven; Øystein Bruserud
Journal:  Proteomes       Date:  2016-08-22

8.  Directed Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase.

Authors:  Renhua Huang; Pete Fang; Zengping Hao; Brian K Kay
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

Review 9.  Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.

Authors:  Erica J Brodie; Simona Infantino; Michael S Y Low; David M Tarlinton
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

10.  Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL.

Authors:  Bin Li; Guangsen Zhang; Cui Li; Ruijuan Li; Jingchen Lu; Zhengxi He; Quan Wang; Zhenzi Peng; Jun Wang; Yeping Dong; Chunfang Zhang; Jie Qiong Tan; Nacef Bahri; Yuexiang Wang; Chaojun Duan
Journal:  Oncotarget       Date:  2016-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.